Management of non-small-cell lung cancer: recent developments
Non-small-cell lung cancer is one of the leading causes of deaths from cancer worldwide.
Therefore, improvements in diagnostics and treatments are urgently needed. In this review …
Therefore, improvements in diagnostics and treatments are urgently needed. In this review …
[HTML][HTML] ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
Highlights•A virtual consensus on the management of EGFR-mutant NSCLC was organized
by the ESMO, including 34 experts from 18 countries.•The experts compiled …
by the ESMO, including 34 experts from 18 countries.•The experts compiled …
Non–small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology
This selection from the NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC)
focuses on targeted therapies and immunotherapies for metastatic NSCLC, because …
focuses on targeted therapies and immunotherapies for metastatic NSCLC, because …
[HTML][HTML] Comprehensive genomic characterization of squamous cell lung cancers
Cancer Genome Atlas Research Network - Nature, 2012 - ncbi.nlm.nih.gov
Lung squamous cell carcinoma (lung SqCC) is a common type of lung cancer, causing
approximately 400,000 deaths per year worldwide. Genomic alterations in lung SqCC have …
approximately 400,000 deaths per year worldwide. Genomic alterations in lung SqCC have …
[HTML][HTML] 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J Vansteenkiste, L Crino, C Dooms, JY Douillard… - Annals of …, 2014 - Elsevier
To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …
[HTML][HTML] Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
KM Kerr, L Bubendorf, MJ Edelman, A Marchetti… - Annals of …, 2014 - Elsevier
To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The Second …
consensus conferences to focus on specific issues in each type of tumour. The Second …
Non–small cell lung cancer
Most patients with non–small cell lung cancer (NSCLC) are diagnosed with advanced
cancer. These guidelines only include information about stage IV NSCLC. Patients with …
cancer. These guidelines only include information about stage IV NSCLC. Patients with …
Targeted agents in the third-/fourth-line treatment of patients with advanced (stage III/IV) non-small cell lung cancer (NSCLC)
CJ Langer, T Mok, PE Postmus - Cancer treatment reviews, 2013 - Elsevier
The prognosis for patients with relapsed/progressive non-small cell lung cancer (NSCLC)
remains poor. For first-line therapy, a number of platinum-based regimens are standard; …
remains poor. For first-line therapy, a number of platinum-based regimens are standard; …
[HTML][HTML] 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
B Besse, A Adjei, P Baas, P Meldgaard, M Nicolson… - Annals of …, 2014 - Elsevier
To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …
Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non–small cell lung cancer: a multicenter …
N Navani, JM Brown, M Nankivell… - American journal of …, 2012 - atsjournals.org
Rationale: The current management of advanced non–small cell lung cancer (NSCLC)
requires differentiation between squamous and nonsquamous subtypes as well as …
requires differentiation between squamous and nonsquamous subtypes as well as …